A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
DualityBio Inc.
University of Nebraska
City of Hope Medical Center
Actym Therapeutics, Inc.
Merck Sharp & Dohme LLC
Elicio Therapeutics
Shanghai Bao Pharmaceuticals Co., Ltd.
Tempus AI
Elevation Oncology